Back to investors
MERCK & CO., INC. 13F Portfolio
MERCK & CO., INC.
Latest SEC 13F filing: 2026-06-30
MERCK & CO., INC. runs MERCK & CO., INC. and currently holds 13 stock positions, which is fewer than the average of 231 among the investors we track. The portfolio is valued at approximately $526.41M. Their top holdings are MRNA, KYMR, AKTS, TRDA, VRDN. The top five represent 56.1% of reported portfolio weight. MERCK & CO., INC. ranks #201 out of 1000 investors tracked by Alpha Score. In the most recent quarter, MERCK & CO., INC. initiated 1 new position. Their current best-performing preview position is AKTS with returns of +80.16%.
Sign in to enable email alerts for this investor.
Top 5 Holdings
MRNA30.7%
KYMR16.8%
AKTS5.8%
TRDA2.4%
VRDN0.3%
Top 5: 56.1%
Portfolio Returns
1 Year
+124.62%
#44/10003 Year
+88.31%
#314/10005 Year
+88.31%
#355/1000Portfolio Value
$526.41M
Alpha Score
92.0
#201 of 1000
Holdings
13
Showper page
MERCK & CO., INC. Current 13F Holdings
Reported holdings from MERCK & CO., INC.'s latest SEC 13F filing, ranked by portfolio weight.
13 stock holdings
| Holding | Weight | Avg Buy | Current | Return | Quarter Change |
|---|---|---|---|---|---|
 MRNA MODERNA INC | 30.71% | $41.58 | $225.00 | +441.13% | Held |
 KYMR KYMERA THERAPEUTICS INC | 16.82% | $40.23 | $112.40 | +179.39% | Held |
 AKTS AKTIS ONCOLOGY INC | 5.83% | $17.89 | $18.15 | +1.45% | Held |
 TRDA ENTRADA THERAPEUTICS INC | 2.43% | $7.36 | $5.67 | -22.96% | New Buy |
 VRDN VIRIDIAN THERAPEUTICS INC | 0.33% | $19.17 | $18.66 | -2.66% | Held |
Showing 1-10 of 13